CLB Core Laboratories N V

Price (delayed)

$19.13

Market cap

$885.86M

P/E Ratio

91.1

Dividend/share

$0.04

EPS

$0.21

Enterprise value

$1.11B

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
CLB's equity is up by 14% YoY and by 3.4% from the previous quarter
CLB's debt is down by 11% YoY
The stock's price to earnings (P/E) is 74% more than its 5-year quarterly average of 52.4 and 22% more than its last 4 quarters average of 74.5
CLB's net income has dropped by 51% since the previous quarter and by 48% year-on-year

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.31M
Market cap
$885.86M
Enterprise value
$1.11B
Valuations
Price to earnings (P/E)
91.1
Price to book (P/B)
5.47
Price to sales (P/S)
1.86
EV/EBIT
33.93
EV/EBITDA
21.82
EV/Sales
2.33
Earnings
Revenue
$477.17M
EBIT
$32.81M
EBITDA
$51.01M
Free cash flow
$21.11M
Per share
EPS
$0.21
Free cash flow per share
$0.46
Book value per share
$3.5
Revenue per share
$10.31
TBVPS
$10.31
Balance sheet
Total assets
$584.92M
Total liabilities
$418.53M
Debt
$249.36M
Equity
$161.79M
Working capital
$102.43M
Liquidity
Debt to equity
1.54
Current ratio
2.03
Quick ratio
1.21
Net debt/EBITDA
4.46
Margins
EBITDA margin
10.7%
Gross margin
20.2%
Net margin
2%
Operating margin
7%
Efficiency
Return on assets
1.7%
Return on equity
6.2%
Return on invested capital
5.3%
Return on capital employed
6.8%
Return on sales
6.9%
Dividend
Dividend yield
0.21%
DPS
$0.04
Payout ratio
19%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
2.52%
1 week
-4.78%
1 month
-26.48%
1 year
-55.06%
YTD
-14.25%
QTD
-39.52%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$477.17M
Gross profit
$96.47M
Operating income
$33.25M
Net income
$9.73M
Gross margin
20.2%
Net margin
2%
CLB's net margin has plunged by 53% YoY and by 52% from the previous quarter
CLB's net income has dropped by 51% since the previous quarter and by 48% year-on-year
The operating margin has decreased by 29% YoY and by 27% from the previous quarter
Core Laboratories N V's operating income has decreased by 27% QoQ and by 24% YoY

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
91.1
P/B
5.47
P/S
1.86
EV/EBIT
33.93
EV/EBITDA
21.82
EV/Sales
2.33
The stock's price to earnings (P/E) is 74% more than its 5-year quarterly average of 52.4 and 22% more than its last 4 quarters average of 74.5
Core Laboratories N V's EPS has plunged by 51% from the previous quarter and by 50% YoY
The P/B is 69% below the 5-year quarterly average of 17.7 and 39% below the last 4 quarters average of 9.0
CLB's equity is up by 14% YoY and by 3.4% from the previous quarter
CLB's price to sales (P/S) is 55% lower than its 5-year quarterly average of 4.1 and 38% lower than its last 4 quarters average of 3.0
The company's revenue rose by 8% YoY

Efficiency

How efficient is Core Laboratories N V business performance
The return on equity has dropped by 72% year-on-year and by 52% since the previous quarter
The ROA has plunged by 50% from the previous quarter and by 47% YoY
Core Laboratories N V's ROS has decreased by 29% YoY and by 27% from the previous quarter
The return on invested capital has declined by 25% since the previous quarter and by 17% year-on-year

Dividends

What is CLB's dividend history
DPS
$0.04
Dividend yield
0.21%
Payout ratio
19%
Recent dividends

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 40% greater than the total liabilities
The quick ratio has decreased by 10% YoY and by 4% QoQ
CLB's current ratio is down by 6% year-on-year and by 2.4% since the previous quarter
CLB's debt is 54% more than its equity
The debt to equity has decreased by 22% YoY and by 3.8% QoQ
CLB's equity is up by 14% YoY and by 3.4% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.